Skip to main content
Global
Regions
WHO Regional websites
Africa
Americas
South-East Asia
Europe
Eastern Mediterranean
Western Pacific
Countries
Countries, territories and areas in the WHO Western Pacific Region:
American Samoa (USA)
Australia
Brunei Darussalam
Cambodia
China
Cook Islands
Fiji
French Polynesia (France)
Guam (USA)
Hong Kong SAR (China)
Indonesia
Japan
Kiribati
Lao People's Democratic Republic
Macao SAR (China)
Malaysia
Marshall Islands
Micronesia, Federated States of
Mongolia
Nauru
New Caledonia (France)
New Zealand
Niue
Northern Mariana Islands (USA)
Palau
Papua New Guinea
Philippines
Pitcairn Islands (UK)
Republic of Korea
Samoa
Singapore
Solomon Islands
Tokelau
Tonga
Tuvalu
Vanuatu
Viet Nam
Wallis and Futuna (France)
When autocomplete results are available use up and down arrows to review and enter to select.
Western Pacific
Japan
Home
Health Topics
Our work
News
Emergencies
About us
Home
/
News
/
Detail Global
/
Medical Product Alert N°2/2026: Falsified JAKAVI (ruxolitinib)
Medical Product Alert N°2/2026: Falsified JAKAVI (ruxolitinib)
Falsified JAKAVI (ruxolitinib) identified in the WHO Eastern Mediterranean and European regions
16 June 2026
Medical product alert
Geneva
Related
WHO Medical Product Alert N°2/2026
